FADS2: Fatty Acid Desaturase 2 – Key Enzyme in Polyunsaturated Fatty Acid Synthesis

Comprehensive biomedical resource for FADS2 gene, including genomic data, expression, mutations, and disease associations.

Gene Information Card

Symbol FADS2
Full Name Fatty Acid Desaturase 2
Gene Type protein-coding
Chromosomal Location 11q12.2
NCBI Gene ID 9415 ncbi.nlm.nih.gov/gene/9415
Ensembl ID ENSG00000134824
UniProt ID O95864
OMIM ID 606149
HGNC ID 3575
Aliases D6D, DES6, FADSD6, SLL0262

Description

FADS2 encodes delta-6 desaturase (D6D), a rate-limiting enzyme in the biosynthesis of long-chain polyunsaturated fatty acids (LC-PUFAs) such as arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid. It catalyzes the desaturation of linoleic acid (18:2n-6) to gamma-linolenic acid (18:3n-6) and alpha-linolenic acid (18:3n-3) to stearidonic acid (18:4n-3). The gene is primarily expressed in liver, brain, and adrenal glands.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
FADS2 deficiency (OMIM #606149) Loss-of-function mutations impair LC-PUFA synthesis, leading to neurological and growth abnormalities. ClinVar, OMIM
Metabolic syndrome Reduced FADS2 activity is associated with altered fatty acid profiles and increased risk of insulin resistance. NCBI Gene, PubMed
Atopic dermatitis Polymorphisms in FADS2 correlate with lower serum LC-PUFA levels and higher risk of eczema. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Brain 8.3 Medium
Adrenal gland 7.1 Medium
Small intestine 5.9 Medium
Kidney 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 10.1 Hepatocellular carcinoma cell line
SH-SY5Y 6.8 Neuroblastoma cell line
Caco-2 5.4 Colorectal adenocarcinoma cell line
HEK293 2.3 Embryonic kidney cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.967C>T (p.Arg323*) Nonsense Rare Loss of function; truncation of D6D enzyme
c.1061G>A (p.Arg354His) Missense 0.1% in European populations Reduced enzymatic activity; associated with altered PUFA levels
c.1487T>C (p.Leu496Pro) Missense <0.01% Impaired desaturase activity; reported in metabolic syndrome
Mutation functional classification

Loss of Function (LOF)

Nonsense and missense mutations (e.g., p.Arg323*, p.Arg354His) reduce or abolish delta-6 desaturase activity, impairing LC-PUFA synthesis.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in FADS2.

Dominant Negative (DN)

No evidence of dominant-negative effects for FADS2 mutations.

Gene Ontology (GO)

• GO:0006636 – fatty acid desaturation • GO:0016215 – delta6-fatty-acid desaturase activity
• GO:0005783 – endoplasmic reticulum • GO:0005504 – iron ion binding
• GO:0004768 – stearoyl-CoA 9-desaturase activity

Pathways

Alpha-linolenic acid metabolism (KEGG: hsa00592)
Linoleic acid metabolism (KEGG: hsa00591)
Biosynthesis of unsaturated fatty acids (KEGG: hsa01040)

Protein Summary

The FADS2 protein (O95864) is a 444-amino acid, membrane-bound desaturase localized to the endoplasmic reticulum. It contains a cytochrome b5-like heme-binding domain and three histidine-rich motifs essential for catalytic activity. The enzyme introduces a double bond at the delta-6 position of 18-carbon fatty acids, a critical step in LC-PUFA production. Structural variants can alter substrate specificity and activity, impacting lipid homeostasis.

Related Products

Product name Cat.No. Species Gene ID
FADS2 Knockout HEK293 Cell Line EDC09656 Human 9415 Details Get a Quote
FADS2 Knockout A-549 Cell Line EDJ-KQ30799 Human 9415 Details Get a Quote
FADS2 Knockout HCT 116 Cell Line EDJ-KQ30800 Human 9415 Details Get a Quote
FADS2 Knockout HeLa Cell Line EDJ-KQ30801 Human 9415 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: